![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Champions Oncology Inc | NASDAQ:CSBR | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.02 | -0.39% | 5.12 | 4.68 | 5.18 | 5.07 | 4.93 | 5.06 | 1,739 | 01:00:00 |
Delaware
|
001-11504
|
52-1401755
|
(State or Other Jurisdiction
|
(Commission File Number)
|
(IRS Employer
|
of Incorporation)
|
|
Identification No.)
|
|
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
|
|
|
|
|
|
Item 5.07.
|
Submission of Matters to a Vote of Security Holders.
|
Director Nominee
|
|
Votes For
|
|
Votes Withheld
|
Ronnie Morris, M.D.
|
|
9,670,839
|
|
498,323
|
Joel Ackerman
|
|
9,639,721
|
|
529,441
|
David Sidransky
|
|
8,634,771
|
|
1,534,391
|
Daniel Mendelson
|
|
9,889,190
|
|
208,834
|
Abba David Poliakoff
|
|
9,960,328
|
|
208,834
|
Scott R. Tobin
|
|
10,025,199
|
|
143,963
|
Philip Breitfeld
|
|
9,588,601
|
|
580,561
|
Votes For
|
|
Votes Against
|
|
Abstain
|
10,168,385
|
|
769
|
|
8
|
Votes For
|
|
Votes Against
|
|
Abstain
|
10,119,809
|
|
40,553
|
|
8,800
|
|
|
CHAMPIONS ONCOLOGY, INC.
|
|
|
|
(Registrant)
|
|
|
|
|
|
Date: October 16, 2018
|
|
By:
|
/s/ David Miller
|
|
|
|
David Miller
|
|
|
|
Chief Financial Officer
|
1 Year Champions Oncology Chart |
1 Month Champions Oncology Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions